Keywords: alizyme, expects, results, phase, ii, trial, colal-pred
Alizyme expects results from Phase II trial of Colal-Pred
Article | 07 January 2002
Alizyme of the UK has completed dosing in its Phase II clinical trial ofColal-Pred (prednisolone metasulphobenzoate; formerly ATL-2502) in mild-to-moderate ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
